Aachen, Germany

Gueven Edgue

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2018-2019.

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gueven Edgue: Innovator in Malaria Vaccine Development

Introduction

Gueven Edgue is a prominent inventor based in Aachen, Germany. He has made significant contributions to the field of malaria vaccine development, holding a total of 3 patents. His work focuses on creating innovative solutions to combat malaria, a disease that continues to pose a major health challenge worldwide.

Latest Patents

Gueven Edgue's latest patents include groundbreaking technologies in malaria vaccines. One of his notable inventions is a three-component multistage malaria vaccine. This technology involves novel malaria vaccines composed of different recombinant proteins, particularly recombinant fusion proteins that include various antigens from the pre-erythrocytic, blood, and sexual stages of the malaria parasite. These proteins are designed to be used in a mixture vaccine formulation to elicit protective immune responses in humans. Additionally, he has developed nucleic acid molecules encoding these recombinant proteins, vectors, and host cells containing the nucleic acids, along with methods for their preparation and production. His patents also cover antibodies induced by these malaria vaccines, which can be utilized for passive immunotherapy.

Another significant patent is the multi-component multistage malaria vaccine. This invention also comprises different recombinant proteins and fusion proteins that target various stages of the malaria parasite. Similar to his previous patent, these proteins are intended for use in a mixture vaccine formulation to stimulate protective immune responses in humans. The patent includes details on nucleic acid molecules, vectors, and methods for producing these proteins, as well as the antibodies generated through their use.

Career Highlights

Gueven Edgue is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to focus on innovative research and development in the field of vaccines.

Collaborations

Throughout his career, Gueven has collaborated with notable colleagues, including Veronique Beiss and Andreas Reimann. These collaborations have contributed to the advancement of his research and the development of effective malaria vaccines.

Conclusion

Gueven Edgue is a dedicated inventor whose work in malaria vaccine development is making a significant impact in the fight against this disease. His innovative patents and collaborations highlight his commitment to advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…